转自：智通财经 注：智通财经VIP为内容资讯产品，并非投资建议。以下内容仅为资讯价值展示非对相关公 司的推荐建议，非未来走势预测。投资有风险，入市需谨慎。 想要借智通财经VIP前瞻锚定市场热点，12.12大促将是年末屯货 智启2026投研新局的黄金 窗口期。 活动最后1天，栏目限时特惠。多买多省，屯货更"惠"！选订12个月钜惠8折还能叠加满减 券，再享折上折。 贴心提醒，新客有礼！新用户完成注册即可解锁新手专属礼包，助您轻松获取深度财经内 容： 28元单篇解锁券×6张：注册成功立即到账，单篇付费内容随心看； 满318元立减40元：订阅付费资讯直接抵扣，性价比拉满； 满518元立减60元：高端栏目订阅专属福利，省心又省钱！ 新客首购再享额外礼赠，订阅 3或6个月加赠对应栏目5天服务期 + 会员专属服务，订阅 12 个月加赠对应栏目30天服务期 + 会员专属服务。 C 厕联社 财经通讯社 | 准确·快速·权威·专业 VIP SHANCE Daily N 机会目报 星期四 18 情绪指数 47 分 | 涨停 71 VS 跌停 8 (含 st) 上证指数 深圳成指 创业板指 3876.37 13053.97 3107 ...

美年大健康产业控股股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 美年大健康产业控股股份有限公司（以下简称"公司"或"本公司"）股票（证 券简称：美年健康；证券代码：002044）连续两个交易日内（2025 年 12 月 17 日、12 月 18 日）收盘价格涨幅偏离值累计超过 20%，根据《深圳证券交易所交 易规则》的有关规定，属于股票交易异常波动情形。 二、公司关注、核实情况的说明 经公司自查并对实际控制人发函就近期公司股票发生异动情况进行了核实， 现就有关情况说明如下： 1.截至本公告披露日，公司前期披露的信息不存在需要更正、补充之处。 证券代码：002044 证券简称：美年健康 公告编号：2025-088 2.公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息。 3.公司近期经营情况正常，内外部经营环境未发生重大变化。 4.经核查，公司和实际控制人不存在关于本公司的应披露而未披露的重大事 项或处于筹划阶段的重大事项。 5.经核查，公司实际控制人在股 ...

美年健康公告称，公司股票（证券代码：002044）在2025年12月17日、18日连续两个交易日内收盘价格 涨幅偏离值累计超过20%，属股票交易异常波动情形。经自查，公司前期披露信息无需更正、补充，未 发现公共传媒报道可能影响股价的未公开重大信息，近期经营正常，内外部环境无重大变化，公司及实 控人无应披露未披露重大事项，实控人在此期间无买卖公司股票情形。公司提醒投资者注意风险。 ...

Group 1 - The medical services sector increased by 0.47% compared to the previous trading day, with Meiyan Health leading the gains [1] - The Shanghai Composite Index closed at 3876.37, up by 0.16%, while the Shenzhen Component Index closed at 13053.98, down by 1.29% [1] - A table detailing the individual stock performance within the medical services sector was provided [1] Group 2 - The net inflow of main funds into the medical services sector was 172 million yuan, while retail funds saw a net inflow of 254 million yuan [2] - Conversely, speculative funds experienced a net outflow of 427 million yuan [2] - A table showing the fund flow for individual stocks in the medical services sector was included [2]

12月18日，美年健康大宗交易成交35万股，成交额210.7万元，占当日总成交额的0.07%，成交价6.02 元，较市场收盘价6.02元持平。 | 权益类证券大宗交易(协议交易) | | | | | | | 团 下载 | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券代码 | 证券简称 | 成交价格 (元) | 成交量 (万股/万份) | 成交金额 (万元) | 买方营业部 | 卖方营业部 | | 2025-12-18 | 002044 | 美年健康 | 6.02 | 35.00 | | 210.70 西部证券股份有限 | 华安证券股份有限 | | | | | | | | 公司西安东大街证 劳营业部 | 公司广东分公司 | ...

Group 1 - The family doctor concept sector rose by 3.86%, ranking second among concept sectors, with 22 stocks increasing, including a 20% limit up for Shuyupingmin and a limit up for Meinian Health [1] - The top gainers in the family doctor sector included Haixia Innovation, Weining Health, and Sichuang Medical, with increases of 16.39%, 11.11%, and 5.77% respectively [1] - The sector saw a net inflow of 1.544 billion yuan from main funds, with 18 stocks receiving net inflows, and five stocks exceeding 50 million yuan in net inflow [2] Group 2 - The leading stocks in terms of net inflow ratio were Haixia Innovation, Meinian Health, and Weining Health, with net inflow ratios of 14.36%, 13.05%, and 12.89% respectively [3] - The top three stocks by main fund inflow were Haixia Innovation with 489 million yuan, Meinian Health with 415 million yuan, and Weining Health with 347 million yuan [3][4] - The family doctor concept sector had a total of 15 stocks with significant net inflows, indicating strong investor interest [2][3]

Market Overview - The three major indices showed mixed performance, with the Shanghai Composite Index rising by 0.16%, while the Shenzhen Component Index fell by 1.29% and the ChiNext Index dropped by 2.17% [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion compared to the previous trading day [1] - Nearly 2,900 stocks in the market experienced gains, with sectors such as pharmaceuticals, banking, and retail leading the rise, while battery and power grid equipment sectors faced declines [1] Investment Opportunities - The banking sector saw a rebound, with Shanghai Bank rising over 3% [1] - The retail sector performed strongly, with Central Plaza and Shanghai Jiubai hitting the daily limit [1] - The commercial aerospace sector was active, with Shengyang Technology achieving consecutive gains and Shunhao shares hitting the daily limit [1] - The pharmaceutical commercial sector continued its strong performance, with Luyan Pharmaceutical achieving consecutive gains and Zhongyao Holdings hitting the limit four times in seven days [1] Fund Performance - The Guotou Silver LOF fund has seen a significant surge in its secondary market price, with a peak premium exceeding 40% and a closing premium of 35.9% [2][3] - The fund has experienced a cumulative increase of over 70% in 17 trading days since November 24, with an annual increase exceeding 173% [7] - The fund has issued eight risk warning announcements regarding its premium, indicating potential risks for investors [8] AI Healthcare Sector - The AI healthcare sector has been active, with multiple stocks hitting the daily limit, including Huaren Health and Shuyupingmin [11] - Ant Group announced an upgrade of its AI health application, now named "Ant Ai Fu," focusing on health management [11] - Baidu's Wenxin Health Manager was also upgraded, positioning itself as a comprehensive family doctor [11] - The Chinese pharmaceutical industry is witnessing significant international collaborations, such as the partnership between Yaoyou Pharmaceutical and Pfizer, involving over 2 billion USD [15] Commercial Aerospace and Satellite Navigation - The commercial aerospace and satellite navigation sectors are experiencing heightened activity, with stocks like Xingchen Technology and Tianyin Machinery seeing significant gains [16][19] - The Ministry of Industry and Information Technology has proposed optimizing business access to promote the satellite communication industry, aiming for over 10 million users by 2030 [22] - The GW satellite constellation plan has launched 116 satellites, with a target of deploying 10% of the planned satellites by 2026 [23]

上天天基金APP搜索777注册即可领500元券包，优选基金10元起投！限量发放！先到先得！ 大家好，不好意思，又来找下跌原因了。 A股下跌 12月18日，A股指数普遍下跌，仅沪指一枝独秀。截至收盘， 沪指涨0.16%，深成指跌 1.29%，创业板指跌2.17%。 两市共2845只个股上涨，73只个股涨停，2416只个股下跌。 AI医疗概念股集体走强，华人健康、塞力医疗等涨停。 消息面上，近日蚂蚁集团正式推出AI 健康应用"蚂蚁阿福"，月活跃用户规模超1500万，并登上苹果应用商店下载榜第二位。市场 解读为AI技术与健康管理场景的深度融合有望开启新增长空间，从而提振了板块整体情绪。 | 代码 | 名称 | | 张帽% | 现价 | | --- | --- | --- | --- | --- | | 688546 | 嘉和美康 | ાર | 20.01 | 25.67 | | 301408 | 华人健康 | R | 20.00 | 21.84 | | 300523 | 卫宁健康 | R | 11.11 | 9.50 | | 002044 | 美年健康 | R | 10.05 | 6.02 | | 603716 | ...

【导读】又来找原因啦 大家好，不好意思，又来找下跌原因了。 隔夜美股科技板块大跌，泰勒以为这次我们会走出独立行情，没想到还是想多了！ | 880005 张跌家数 | | | | --- | --- | --- | | 글 바 | 涨停 | | | 涨幅 | > 7% | 108 | | 涨幅 | 5-7% 1 | 63 | | 涨幅 | 3-5% | 233 | | 涨幅 | 0-3% | 2441 | | 跌幅 | 0-3% | 2090 | | 跌幅 | 3-5% | 243 | | 跌幅 | 5-7% | 59 | | 跌幅 | > 7% | 24 | | 日中 | 跌停 | 8 | | 上涨家数 | | 2845 | | 下跌家数 | | 2416 | | 平盘停牌 | | 199 | | 总品种数 | | 5460 | | 总成交额 | | 16768.01亿 | | 总成交量 | | 106025.5万 | | 涨家增减 | | 115 | | 涨家增幅 | | 4.21% | | 指数量比 | | 0.88 | AI医疗概念股集体走强，华人健康（301408）、塞力医疗（603716）等涨停。消 ...

Group 1 - A-shares experienced significant market activity on December 18, with 73 stocks hitting the daily limit up and 8 stocks hitting the limit down [1] - The pharmaceutical commercial sector showed strong performance, with major stocks like Zhongya Holdings achieving 4 limit ups in 7 days, and Luyan Pharmaceutical achieving 2 consecutive limit ups [1] - The satellite internet sector also saw gains, with *ST Chengchang achieving 9 limit ups in 10 days, and Shengyang Technology achieving 2 consecutive limit ups [1] - The AI healthcare sector rose, with Meinian Health achieving 2 consecutive limit ups and Jiahe Meikang hitting the limit up [1] Group 2 - Stocks with consecutive limit ups included Baida Group and *ST Ningke with 6 consecutive limit ups, and Shengtong Energy with 5 consecutive limit ups [1] - Other notable stocks included Pinao with 4 consecutive limit ups, and Junda Co. and Jiuzhou Wang with 3 limit ups in 5 days [1] - On the downside, *ST Aowei faced a continuous decline with 7 consecutive limit downs, along with *ST Huarong and *ST Fanli also hitting the limit down [2]